Medical Cannabis for Gynecologic Pain Conditions: A Systematic Review
- PMID: 35576357
- DOI: 10.1097/AOG.0000000000004777
Medical Cannabis for Gynecologic Pain Conditions: A Systematic Review
Conflict of interest statement
Financial Disclosure The authors did not report any potential conflict of interest.
Comment on
-
Medical Cannabis for Gynecologic Pain Conditions: A Systematic Review.Obstet Gynecol. 2022 Feb 1;139(2):287-296. doi: 10.1097/AOG.0000000000004656. Obstet Gynecol. 2022. PMID: 35104069
References
-
- Liang AL, Gingher EL, Coleman JS. Medical cannabis for gynecologic pain conditions: a systematic review. Obstet Gynecol 2022;139:287–96. doi: 10.1097/AOG.0000000000004656 - DOI
-
- American Psychiatric Association. Position statement in opposition to cannabis as medicine. Accessed March 22, 2022. https://www.psychiatry.org/File%20Library/About-APA/Organization-Documen...
-
- Smart Approaches to Marijuana. Center for peer reviewed marijuana research studies. Accessed January 29, 2022. https://learnaboutsam.org/research-studies-on-marijuana/
-
- O'Sullivan SE, Kendall DA. Cannabinoid activation of peroxisome proliferator-activated receptors: potential for modulation of inflammatory disease. Immunobiology 2010;215:611–6. doi: 10.1016/j.imbio.2009.09.007 - DOI
-
- International Association for the Study of Pain. IASP position statement on the use of cannabinoids to treat pain. Accessed January 29, 2022. https://www.iasp-pain.org/publications/iasp-news/iasp-position-statement...
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical